A detailed history of Dearborn Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Dearborn Partners LLC holds 3,578 shares of AMGN stock, worth $1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,578
Previous 3,379 5.89%
Holding current value
$1 Million
Previous $1.06 Million 9.19%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$309.38 - $337.38 $61,566 - $67,138
199 Added 5.89%
3,578 $1.15 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $155,548 - $189,031
592 Added 21.24%
3,379 $1.06 Million
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $218,053 - $263,218
-811 Reduced 22.54%
2,787 $792,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $18,154 - $20,480
71 Added 2.01%
3,598 $1.04 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $116,977 - $145,231
535 Added 17.88%
3,527 $947,000
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $42,425 - $50,167
198 Added 7.09%
2,992 $664,000
Q1 2023

May 04, 2023

SELL
$225.79 - $275.2 $276,818 - $337,395
-1,226 Reduced 30.5%
2,794 $675,000
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $251,245 - $319,237
-1,097 Reduced 21.44%
4,020 $1.06 Million
Q3 2022

Oct 25, 2022

BUY
$224.46 - $253.15 $13,467 - $15,189
60 Added 1.19%
5,117 $1.15 Million
Q2 2022

Jul 20, 2022

BUY
$230.71 - $256.74 $40,143 - $44,672
174 Added 3.56%
5,057 $1.23 Million
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $25,654 - $28,380
117 Added 2.45%
4,883 $1.18 Million
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $142,000 - $162,506
714 Added 17.62%
4,766 $1.07 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $35,449 - $41,532
167 Added 4.3%
4,052 $862,000
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $185,696 - $206,016
795 Added 25.73%
3,885 $947,000
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $226,348 - $263,772
-1,020 Reduced 24.82%
3,090 $769,000
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $34,620 - $41,227
-160 Reduced 3.75%
4,110 $945,000
Q3 2020

Oct 20, 2020

BUY
$234.65 - $260.95 $6,100 - $6,784
26 Added 0.61%
4,270 $1.09 Million
Q2 2020

Jul 30, 2020

BUY
$197.81 - $242.74 $6,527 - $8,010
33 Added 0.78%
4,244 $1 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $102,965 - $136,560
-565 Reduced 11.83%
4,211 $854,000
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $268,110 - $344,614
1,417 Added 42.19%
4,776 $1.15 Million
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $43,527 - $52,155
250 Added 8.04%
3,359 $650,000
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $136,027 - $159,454
816 Added 35.59%
3,109 $573,000
Q1 2019

May 01, 2019

SELL
$180.87 - $203.88 $292,466 - $329,673
-1,617 Reduced 41.36%
2,293 $436,000
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $160,024 - $186,800
-897 Reduced 18.66%
3,910 $761,000
Q3 2018

Oct 24, 2018

BUY
$185.29 - $208.89 $109,691 - $123,662
592 Added 14.05%
4,807 $996,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $66,918 - $75,163
403 Added 10.57%
4,215 $778,000
Q1 2018

May 01, 2018

SELL
$169.43 - $198.0 $15,587 - $18,216
-92 Reduced 2.36%
3,812 $650,000
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $9,702 - $11,078
-58 Reduced 1.46%
3,904 $728,000
Q2 2017

Aug 09, 2017

BUY
N/A
3,962
3,962 $682,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.